Clinical Outcomes of Gemcitabine Plus Nab-Paclitaxel-Based Chemoradiotherapy in a Multidisciplinary Treatment Strategy for Locally Advanced Pancreatic Cancer (NUPAT-05): A Prospective, Single-Arm, Phase II Study.
It is suggested that GnP-based CRT showed encouraging clinical activity with manageable toxicity in patients with LAPC, and future studies are needed to validate the additional benefits of radiotherapy.